This is a $138,356.92 firm fixed price purchase order awarded by the Department of Health and Human Services to Bio-Active Company LIMITED, a for-profit limited liability company in Thailand. The contract is for a "NGS PLATFORM SEQUENCING SYSTEM" to support the Centers for Disease Control and Prevention's (CDC) infectious disease monitoring and research programs in Thailand. Bio-Active Company LIMITED has a history of providing genetic sequencing systems, reagents, and testing...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Bio-Active Company LIMITED, a for-profit limited liability company, for the acquisition of lab reagents for whole genome sequencing with Illumina instruments on behalf of the CDC's Division of Global Health Protection (DGHP) in Thailand. The contract, valued at $81,470.59, has an ultimate completion date of October 31, 2024. Bio-Active Company LIMITED has a history of delivering genetic...
This federal contract award is for "SERVICES ON MISEQ SYSTEM" to be provided by Bio-Active Company LIMITED, a for-profit limited liability company, to the Centers for Disease Control and Prevention (CDC) operating out of a facility in Thailand. The contract, valued at $26,438.95, is a firm fixed price Blanket Purchase Agreement (BPA) call, with a period of performance ending on August 31, 2023. The contract does not have a set-aside designation. Bio-Active Company LIMITED has...
This federal contract award is for services related to the Illumina MiSeq genetic sequencing system. The $26,537.08 firm fixed price contract was issued as a call under a Blanket Purchase Agreement (BPA) held by Bio-Active Company Limited, a for-profit limited liability company based in Thailand. The work is being performed for the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian federal agency. No set-aside designation was used for this award. Bio-Active Company...
The Department of State Bureau of European and Eurasian Affairs awarded a $110,238 firm fixed price purchase order to Bio-Active Company LIMITED of Thailand to acquire reagent kits and DNA sets on behalf of the Centers for Disease Control and Prevention in Thailand. The contract period of performance spans from August 31, 2023 through November 2, 2023 and will deliver requested biological samples and testing materials to support CDC programs in the region. No subcontractors or set aside...
This is a $90,787.88 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Geneplus Company LIMITED, a for-profit limited liability company based in Thailand. The contract is for the procurement of 7500 FAST DX real-time PCR systems, which are biotechnology instruments used for infectious disease research. This contract was not set aside for any specific business category. Geneplus Company LIMITED is the prime contractor and has previously...
The Department of the Army awarded a $178,000 purchase order to Bio-Active Company LIMITED of Thailand to acquire reagents for influenza virus, dengue virus, chikungunya virus, and SARS-CoV-2 virus on behalf of the Centers for Disease Control and Prevention (CDC) Thailand. The firm fixed price order, placed under an unspecified contract vehicle, calls for the delivery of products to support CDC Thailand's viral detection efforts. Performance will occur in Thailand over a three-month period...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order to Dksh (Thailand) Co LTD, a for-profit limited liability company, to provide COBAS Rack Instrument Laboratory Equipment. The total potential value of the contract is $107,000.00 with a completion date of January 21, 2021. This award is associated with a Blanket Purchase Agreement (BPA) the Department of State has with Dksh to supply laboratory reagents and...
This firm fixed price contract was awarded to Bio-Active Company LIMITED, a for-profit limited liability company, to provide services on the Illumina MiSeq sequencing system. The $27,344.86 contract is a call against a previously awarded Blanket Purchase Agreement to support infectious disease monitoring and research conducted by U.S. government health agencies, including the Centers for Disease Control and Prevention (CDC), operating programs in Thailand. No set-aside was used for this award....
This federal contract award, valued at $97,350.00, was issued by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is for the delivery of "SPECIAL GENE EX CONF4 TAC CARDS" and is a Blanket Purchase Agreement (BPA) Call, with a firm fixed price pricing type. The contract has no set-aside designation. Life Technologies Corporation is a manufacturer of scientific instruments, reagents, and...